logo
#

Latest news with #AmericanaRestaurantsInternational

Global Value Stocks: 3 Companies That May Be Priced Below Their Intrinsic Estimates
Global Value Stocks: 3 Companies That May Be Priced Below Their Intrinsic Estimates

Yahoo

time19-05-2025

  • Business
  • Yahoo

Global Value Stocks: 3 Companies That May Be Priced Below Their Intrinsic Estimates

In recent weeks, global markets have experienced a rally, buoyed by the U.S.-China agreement to pause tariffs and cooling inflation rates in the U.S., which have lifted investor sentiment across major indices. Amidst this positive market environment, identifying stocks that are potentially undervalued can be an attractive strategy for investors seeking opportunities that may not yet reflect their intrinsic value. Name Current Price Fair Value (Est) Discount (Est) Shibaura Mechatronics (TSE:6590) ¥7060.00 ¥13927.88 49.3% Shenzhen KSTAR Science and Technology (SZSE:002518) CN¥22.73 CN¥44.81 49.3% GEM (SZSE:002340) CN¥6.23 CN¥12.45 50% Lectra (ENXTPA:LSS) €24.10 €47.47 49.2% H.U. Group Holdings (TSE:4544) ¥3074.00 ¥6135.07 49.9% Dive (TSE:151A) ¥921.00 ¥1813.68 49.2% BalnibarbiLtd (TSE:3418) ¥1165.00 ¥2314.28 49.7% Fuji Oil (TSE:2607) ¥3034.00 ¥6054.67 49.9% illimity Bank (BIT:ILTY) €3.684 €7.28 49.4% True Corporation (SET:TRUE) THB12.40 THB24.64 49.7% Click here to see the full list of 491 stocks from our Undervalued Global Stocks Based On Cash Flows screener. Here's a peek at a few of the choices from the screener. Overview: Americana Restaurants International PLC operates a chain of restaurants across several countries in the Middle East and North Africa, with a market cap of AED18.14 billion. Operations: The company's revenue segments include the Major Gulf Cooperation Council (GCC) region at $1.69 billion, the Lower Gulf at $213.27 million, and North Africa at $179.10 million. Estimated Discount To Fair Value: 12.4% Americana Restaurants International presents an intriguing case for potential undervaluation based on cash flows. The stock is trading at AED2.16, below its estimated fair value of AED2.47, although not significantly undervalued. Recent earnings showed a rise in net income to US$32.65 million from US$28.02 million year-over-year, with revenue growth outpacing the market forecast at 8.9% annually compared to 6.7%. Despite high share price volatility, profit growth forecasts remain robust at 17% annually. The analysis detailed in our Americana Restaurants International growth report hints at robust future financial performance. Take a closer look at Americana Restaurants International's balance sheet health here in our report. Overview: Fertiglobe plc, along with its subsidiaries, is engaged in the production and sale of nitrogen-based products across various regions including Europe, the Americas, Africa, the Middle East, Asia, and Oceania; it has a market cap of AED20.75 billion. Operations: The company's revenue is primarily derived from the production and marketing of owned produced volumes, amounting to $1.99 billion, with an additional $156.30 million generated through third-party trading. Estimated Discount To Fair Value: 14.5% Fertiglobe's current valuation appears slightly below its estimated fair value, trading at AED2.5 compared to an estimated AED2.92. Despite a decline in net income from US$116.3 million to US$72.6 million year-over-year, earnings are projected to grow significantly at 22.7% annually over the next three years, outpacing the market average of 5.2%. However, profit margins have decreased and high debt levels remain a concern for financial stability. Our growth report here indicates Fertiglobe may be poised for an improving outlook. Click to explore a detailed breakdown of our findings in Fertiglobe's balance sheet health report. Overview: Akeso, Inc. is a biopharmaceutical company focused on the research, development, manufacturing, and commercialization of antibody drugs with a market cap of HK$74.95 billion. Operations: The company generates revenue of CN¥2.12 billion from its activities in the research, development, production, and sale of biopharmaceutical products. Estimated Discount To Fair Value: 39.6% Akeso's stock is trading at HK$83.5, significantly below its estimated fair value of HK$138.34, suggesting it may be undervalued based on cash flows. The company anticipates a robust revenue growth rate of 29.6% annually, surpassing the Hong Kong market average. Recent approvals for ivonescimab and penpulimab highlight Akeso's innovative drug development capabilities, though the share price has been volatile recently and recent earnings showed a net loss of CNY 514.52 million for 2024. Upon reviewing our latest growth report, Akeso's projected financial performance appears quite optimistic. Get an in-depth perspective on Akeso's balance sheet by reading our health report here. Access the full spectrum of 491 Undervalued Global Stocks Based On Cash Flows by clicking on this link. Got skin in the game with these stocks? Elevate how you manage them by using Simply Wall St's portfolio, where intuitive tools await to help optimize your investment outcomes. Take control of your financial future using Simply Wall St, offering free, in-depth knowledge of international markets to every investor. Explore high-performing small cap companies that haven't yet garnered significant analyst attention. Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence. Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include ADX:AMR ADX:FERTIGLB and SEHK:9926. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Global Value Stocks: 3 Companies That May Be Priced Below Their Intrinsic Estimates
Global Value Stocks: 3 Companies That May Be Priced Below Their Intrinsic Estimates

Yahoo

time19-05-2025

  • Business
  • Yahoo

Global Value Stocks: 3 Companies That May Be Priced Below Their Intrinsic Estimates

In recent weeks, global markets have experienced a rally, buoyed by the U.S.-China agreement to pause tariffs and cooling inflation rates in the U.S., which have lifted investor sentiment across major indices. Amidst this positive market environment, identifying stocks that are potentially undervalued can be an attractive strategy for investors seeking opportunities that may not yet reflect their intrinsic value. Name Current Price Fair Value (Est) Discount (Est) Shibaura Mechatronics (TSE:6590) ¥7060.00 ¥13927.88 49.3% Shenzhen KSTAR Science and Technology (SZSE:002518) CN¥22.73 CN¥44.81 49.3% GEM (SZSE:002340) CN¥6.23 CN¥12.45 50% Lectra (ENXTPA:LSS) €24.10 €47.47 49.2% H.U. Group Holdings (TSE:4544) ¥3074.00 ¥6135.07 49.9% Dive (TSE:151A) ¥921.00 ¥1813.68 49.2% BalnibarbiLtd (TSE:3418) ¥1165.00 ¥2314.28 49.7% Fuji Oil (TSE:2607) ¥3034.00 ¥6054.67 49.9% illimity Bank (BIT:ILTY) €3.684 €7.28 49.4% True Corporation (SET:TRUE) THB12.40 THB24.64 49.7% Click here to see the full list of 491 stocks from our Undervalued Global Stocks Based On Cash Flows screener. Here's a peek at a few of the choices from the screener. Overview: Americana Restaurants International PLC operates a chain of restaurants across several countries in the Middle East and North Africa, with a market cap of AED18.14 billion. Operations: The company's revenue segments include the Major Gulf Cooperation Council (GCC) region at $1.69 billion, the Lower Gulf at $213.27 million, and North Africa at $179.10 million. Estimated Discount To Fair Value: 12.4% Americana Restaurants International presents an intriguing case for potential undervaluation based on cash flows. The stock is trading at AED2.16, below its estimated fair value of AED2.47, although not significantly undervalued. Recent earnings showed a rise in net income to US$32.65 million from US$28.02 million year-over-year, with revenue growth outpacing the market forecast at 8.9% annually compared to 6.7%. Despite high share price volatility, profit growth forecasts remain robust at 17% annually. The analysis detailed in our Americana Restaurants International growth report hints at robust future financial performance. Take a closer look at Americana Restaurants International's balance sheet health here in our report. Overview: Fertiglobe plc, along with its subsidiaries, is engaged in the production and sale of nitrogen-based products across various regions including Europe, the Americas, Africa, the Middle East, Asia, and Oceania; it has a market cap of AED20.75 billion. Operations: The company's revenue is primarily derived from the production and marketing of owned produced volumes, amounting to $1.99 billion, with an additional $156.30 million generated through third-party trading. Estimated Discount To Fair Value: 14.5% Fertiglobe's current valuation appears slightly below its estimated fair value, trading at AED2.5 compared to an estimated AED2.92. Despite a decline in net income from US$116.3 million to US$72.6 million year-over-year, earnings are projected to grow significantly at 22.7% annually over the next three years, outpacing the market average of 5.2%. However, profit margins have decreased and high debt levels remain a concern for financial stability. Our growth report here indicates Fertiglobe may be poised for an improving outlook. Click to explore a detailed breakdown of our findings in Fertiglobe's balance sheet health report. Overview: Akeso, Inc. is a biopharmaceutical company focused on the research, development, manufacturing, and commercialization of antibody drugs with a market cap of HK$74.95 billion. Operations: The company generates revenue of CN¥2.12 billion from its activities in the research, development, production, and sale of biopharmaceutical products. Estimated Discount To Fair Value: 39.6% Akeso's stock is trading at HK$83.5, significantly below its estimated fair value of HK$138.34, suggesting it may be undervalued based on cash flows. The company anticipates a robust revenue growth rate of 29.6% annually, surpassing the Hong Kong market average. Recent approvals for ivonescimab and penpulimab highlight Akeso's innovative drug development capabilities, though the share price has been volatile recently and recent earnings showed a net loss of CNY 514.52 million for 2024. Upon reviewing our latest growth report, Akeso's projected financial performance appears quite optimistic. Get an in-depth perspective on Akeso's balance sheet by reading our health report here. Access the full spectrum of 491 Undervalued Global Stocks Based On Cash Flows by clicking on this link. Got skin in the game with these stocks? Elevate how you manage them by using Simply Wall St's portfolio, where intuitive tools await to help optimize your investment outcomes. Take control of your financial future using Simply Wall St, offering free, in-depth knowledge of international markets to every investor. Explore high-performing small cap companies that haven't yet garnered significant analyst attention. Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence. Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include ADX:AMR ADX:FERTIGLB and SEHK:9926. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Sign in to access your portfolio

Americana Restaurants achieves higher sales in Q1-25 despite currency devaluation in Egypt
Americana Restaurants achieves higher sales in Q1-25 despite currency devaluation in Egypt

Zawya

time30-04-2025

  • Business
  • Zawya

Americana Restaurants achieves higher sales in Q1-25 despite currency devaluation in Egypt

Americana Restaurants International logged net profits attributable to the owners valued at $32.64 million in the first quarter (Q1) of 2025, up 16.50% year-on-year (YoY) from $28.02 million. The company's revenues jumped by 16.20% to $573.38 million as of 31 March 2025 from $493.50 million in Q1-24, according to the financial results. The cross-listed group delivered robust revenue growth despite softening consumer demand in certain markets, additional days of Ramadan 2025, and the impact from the currency devaluation, primarily in Egypt Basic and diluted earnings per share (EPS) grew by 17.20% YoY to $0.0039 in Q1-25 from $0.0033. This performance was mainly driven by like-for-like sales improvements and the expansion of the store network. During the three-month period, Americana Restaurants opened 14 new stores and launched 46 additional stores from Pizza Hut Oman, bringing the total store count to 2,630 across 12 countries. In 2024, the company's net profits attributable to the shareholders retreated by 38.80% to $158.75 million from $259.46 million in 2023. Source: Mubasher All Rights Reserved - Mubasher Info © 2005 - 2022 Provided by SyndiGate Media Inc. ( Mubasher

Mideast Stocks: Most Gulf markets ease on soft oil, weak earnings
Mideast Stocks: Most Gulf markets ease on soft oil, weak earnings

Zawya

time30-04-2025

  • Business
  • Zawya

Mideast Stocks: Most Gulf markets ease on soft oil, weak earnings

Most of the major stock markets in the Gulf tracked oil prices lower on Wednesday, while weak corporate earnings failed to boost investor sentiment. Oil prices, a catalyst for the Gulf's financial markets, extended declines and were set for their steepest monthly drop in more than three years on Wednesday as the global trade war eroded demand outlook and fears of mounting supply weighed. Saudi Arabia's benchmark index edged 0.1% lower, with oil major Saudi Aramco losing 0.6%. The UAE-based Americana Restaurants International retreated 2.2%, following a sequential fall in first-quarter profit. Abu Dhabi's index eased 0.3%, hit by a 3.7% slide in Abu Dhabi Commercial Bank, following a drop in first-quarter operating income. However, the lender reported a rise in profit. Among other laggards, Multiply Group dropped 2.4% and was poised to extend losses from Tuesday when the investment firm reported a slide in quarterly profit. However, the index's losses were capped by a 1.8% rise in the United Arab Emirates' biggest lender, First Abu Dhabi Bank . On Tuesday, the bank jumped more than 3% after reporting a net profit of 5.13 billion dirhams ($1.40 billion), beating analysts' estimate of 4.24 billion dirhams, according to data compiled by LSEG. Dubai's main share index fell 0.4%, weighed down by a 1.5% decrease in blue-chip developer Emaar Properties . The Qatari index gained 0.4%, led by a 0.8% rise in petrochemical maker Industries Qatar. ($1 = 3.6729 UAE dirham)

Most Gulf markets ease on soft oil, weak earnings
Most Gulf markets ease on soft oil, weak earnings

Reuters

time30-04-2025

  • Business
  • Reuters

Most Gulf markets ease on soft oil, weak earnings

April 30 (Reuters) - Most of the major stock markets in the Gulf tracked oil prices lower on Wednesday, while weak corporate earnings failed to boost investor sentiment. Oil prices, a catalyst for the Gulf's financial markets, extended declines and were set for their steepest monthly drop in more than three years on Wednesday as the global trade war eroded demand outlook and fears of mounting supply weighed. The Reuters Tariff Watch newsletter is your daily guide to the latest global trade and tariff news. Sign up here. Saudi Arabia's benchmark index (.TASI), opens new tab edged 0.1% lower, with oil major Saudi Aramco ( opens new tab losing 0.6%. The UAE-based Americana Restaurants International ( opens new tab retreated 2.2%, following a sequential fall in first-quarter profit. Abu Dhabi's index (.FTFADGI), opens new tab eased 0.3%, hit by a 3.7% slide in Abu Dhabi Commercial Bank ( opens new tab, following a drop in first-quarter operating income. However, the lender reported a rise in profit. Among other laggards, Multiply Group ( opens new tab dropped 2.4% and was poised to extend losses from Tuesday when the investment firm reported a slide in quarterly profit. However, the index's losses were capped by a 1.8% rise in the United Arab Emirates' biggest lender, First Abu Dhabi Bank ( opens new tab. On Tuesday, the bank jumped more than 3% after reporting a net profit of 5.13 billion dirhams ($1.40 billion), beating analysts' estimate of 4.24 billion dirhams, according to data compiled by LSEG. The Qatari index (.QSI), opens new tab gained 0.4%, led by a 0.8% rise in petrochemical maker Industries Qatar ( opens new tab. ($1 = 3.6729 UAE dirham)

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store